Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity
Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity
Recruiting · NCT04232566 · Registry updated 2026-01-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity | Body Weight, Digestive System Diseases, Insulin Resistance, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, fatty liver disease, glucose metabolism disease, hyperinsulinism, liver disorder, metabolic disease, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease, morbid obesity, nutritional disorder, obesity disorder, overnutrition | Recruiting | Not stated | 2026-01-28 | NCT04232566 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mayo Clinic | 970 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mayo Clinic in Arizona | Scottsdale | United States | 191 |